120 related articles for article (PubMed ID: 20138478)
1. CTX-M-35 extended-spectrum beta-lactamase conferring ceftazidime resistance in Citrobacter koseri.
Tian GB; Adams-Haduch JM; Qureshi ZA; Wang HN; Doi Y
Int J Antimicrob Agents; 2010 Apr; 35(4):412-3. PubMed ID: 20138478
[No Abstract] [Full Text] [Related]
2. Novel TEM-type extended-spectrum beta-lactamase, TEM-134, in a Citrobacter koseri clinical isolate.
Perilli M; Mugnaioli C; Luzzaro F; Fiore M; Stefani S; Rossolini GM; Amicosante G
Antimicrob Agents Chemother; 2005 Apr; 49(4):1564-6. PubMed ID: 15793140
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the chromosomal class A beta-lactamase CKO from Citrobacter koseri.
Petrella S; Renard M; Ziental-Gelus N; Clermont D; Jarlier V; Sougakoff W
FEMS Microbiol Lett; 2006 Jan; 254(2):285-92. PubMed ID: 16445758
[TBL] [Abstract][Full Text] [Related]
4. A nosocomial outbreak due to novel CTX-M-2-producing strains of Citrobacter koseri in a hematological ward.
Muta T; Tsuruta N; Seki Y; Ota R; Suzuki S; Shibata N; Kato K; Eto T; Gondo H; Arakawa Y
Jpn J Infect Dis; 2006 Feb; 59(1):69-71. PubMed ID: 16495644
[No Abstract] [Full Text] [Related]
5. In vitro antimicrobial susceptibility of clinical respiratory isolates to ceftazidime-avibactam and comparators (2016-2018).
Piérard D; Stone GG
BMC Infect Dis; 2021 Jun; 21(1):600. PubMed ID: 34162341
[TBL] [Abstract][Full Text] [Related]
6. Detection of Citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece, July 2011.
Mavroidi A; Neonakis I; Liakopoulos A; Papaioannou A; Ntala M; Tryposkiadis F; Miriagou V; Petinaki E
Euro Surveill; 2011 Oct; 16(41):. PubMed ID: 22008199
[TBL] [Abstract][Full Text] [Related]
7. Citrobacter koseri and Citrobacter amalonaticus isolates carry highly divergent beta-lactamase genes despite having high levels of biochemical similarity and 16S rRNA sequence homology.
Underwood S; Avison MB
J Antimicrob Chemother; 2004 Jun; 53(6):1076-80. PubMed ID: 15128725
[TBL] [Abstract][Full Text] [Related]
8. Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient in a cardiac rehabilitation unit.
Caltagirone M; Bitar I; Piazza A; Spalla M; Nucleo E; Navarra A; Migliavacca R
New Microbiol; 2015 Jul; 38(3):387-92. PubMed ID: 26147151
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.
Qing Y; Cao KY; Fang ZL; Huang YM; Zhang XF; Tian GB; Huang X
J Med Microbiol; 2014 Mar; 63(Pt 3):386-392. PubMed ID: 24398232
[TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.
Poirel L; Gniadkowski M; Nordmann P
J Antimicrob Chemother; 2002 Dec; 50(6):1031-4. PubMed ID: 12461028
[TBL] [Abstract][Full Text] [Related]
11. Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
Picão RC; Poirel L; Gales AC; Nordmann P
Antimicrob Agents Chemother; 2009 May; 53(5):2225-6. PubMed ID: 19223647
[No Abstract] [Full Text] [Related]
12. Emergence of a plasmid mediated bla (VIM-1) in Citrobacter koseri: report from the SENTRY Antimicrobial Surveillance Program (Italy).
Castanheira M; Debbia E; Marchese A; Jones RN
J Chemother; 2009 Feb; 21(1):98-100. PubMed ID: 19297281
[No Abstract] [Full Text] [Related]
13. Comparison of beta-lactamase genes in clinical and food bacterial isolates in India.
Shahid M; Malik A; Adil M; Jahan N; Malik R
J Infect Dev Ctries; 2009 Sep; 3(8):593-8. PubMed ID: 19801801
[TBL] [Abstract][Full Text] [Related]
14. Influence of disk preparation on detection of metallo-beta-lactamase-producing isolates by the combined disk assay.
Andrade SS; Picão RC; Campana EH; Nicoletti AG; Pignatari AC; Gales AC
J Clin Microbiol; 2007 Jun; 45(6):2058-60. PubMed ID: 17409202
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime-resistant Klebsiella oxytoca producing an OXY-2-type variant from Switzerland.
Rodríguez-Martínez JM; Poirel L; Nordmann P; Fankhauser C; Francois P; Schrenzel J
Int J Antimicrob Agents; 2008 Sep; 32(3):278-9. PubMed ID: 18602252
[No Abstract] [Full Text] [Related]
16. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K
Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of extended-spectrum β-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2.
Kanamori H; Yano H; Hirakata Y; Endo S; Arai K; Ogawa M; Shimojima M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Kitagawa M; Kunishima H; Kaku M
J Antimicrob Chemother; 2011 Oct; 66(10):2255-62. PubMed ID: 21733965
[TBL] [Abstract][Full Text] [Related]
18. Providencia stuartii with VIM-1 metallo-beta-lactamase.
Miriagou V; Tzouvelekis LS; Flevari K; Tsakiri M; Douzinas EE
J Antimicrob Chemother; 2007 Jul; 60(1):183-4. PubMed ID: 17517828
[No Abstract] [Full Text] [Related]
19. [A novel extended-spectrum beta-lactamase in a ceftazidime-resistant isolate of E. coli].
Cheng Y; Li Y; Chen M
Wei Sheng Wu Xue Bao; 1994 Oct; 34(5):360-6. PubMed ID: 7871780
[TBL] [Abstract][Full Text] [Related]
20. Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance.
Novais A; Cantón R; Coque TM; Moya A; Baquero F; Galán JC
Antimicrob Agents Chemother; 2008 Jul; 52(7):2377-82. PubMed ID: 18443114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
